<DOC>
	<DOCNO>NCT00763971</DOCNO>
	<brief_summary>The main aim study see give LDX child adolescent age 6-17 year ADHD decrease symptom ADHD .</brief_summary>
	<brief_title>Randomized , Double-blind Safety Efficacy Study Lisdexamfetamine Dimesylate ( LDX ) Children Adolescents Aged 6-17</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Lisdexamfetamine Dimesylate</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>1 . Subject male female age 617 year inclusive time consent . 2 . Subject must meet Diagnostic Statistical Manual Mental Disorders , Fourth Edition Text Revision ( DSMIVTR ) criteria primary diagnosis ADHD base detailed psychiatric evaluation . 3 . Subject must Baseline ADHDRSIV total score â‰¥28 . 4 . Subject blood pressure measurement within 95th percentile age , gender , height Screening Baseline . 5 . Subject able swallow capsule . 1 . Subject fail respond one adequate course ( dose duration ) stimulant therapy . One course must longacting formulation . 2 . Subject conduct disorder . Oppositional Defiant Disorder exclusionary . 3 . Subject currently consider suicide risk , previously make suicide attempt prior history , currently , demonstrate active suicidal ideation . 4 . Subject glaucoma . 5 . Subject weigh less 22.7kg ( 50lbs ) . 6 . Subject significantly overweight base Centre Disease Control Prevention Body Mass Index ( BMI ) forage gender specific chart Screening . Significantly overweight define BMI &gt; 97th percentile study . 7 . Subject document allergy , hypersensitivity , intolerance amphetamine methylphenidate . 8 . Subject document allergy , hypersensitivity , intolerance excipients test reference product . 9 . Subject history seizure ( infantile febrile seizure ) , tic disorder , current diagnosis and/or know family history Tourette 's Disorder . 10 . Subject known history symptomatic cardiovascular disease , advance arteriosclerosis , structural cardiac abnormality , cardiomyopathy , serious heart rhythm abnormality , coronary artery disease , serious cardiac problem may place increased vulnerability sympathomimetic effect stimulant drug . 11 . Subject know family history sudden cardiac death ventricular arrhythmia . 12 . Subject well control current ADHD medication acceptable tolerability . 13 . Subject preexist severe gastrointestinal tract narrowing ( pathologic iatrogenic ) .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>